April 22, 2025
New QIAseq panels launched for use on next-generation sequencers to boost analysis of over 700 genes for comprehensive genomic profiling in research and clinical applications Advancing key partnerships: New QIAseq panels to be added to Element Bioscience’s Trinity workflow, new assay in development with Myriad Genetics planned for launch in 2025 QIAGEN Digital Insights introduces [...]
April 22, 2025
Institutes under the Department of Biotechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies Oxford Nanopore Technologies, the global company behind a new generation of nanopore-based molecular sensing technology, [...]
Nikon releases AX NIR with NSPARC to extend super-resolution multicolor imaging
April 22, 2025
Unlocking the power of super-resolution near-infrared imaging for detailed, multichannel observation of biomolecular interactions, benefiting drug discovery research and other fields by illuminating a new level of detail. Nikon Instruments Inc. (Nikon) is pleased to announce the launch of the AX NIR with NSPARC, a super-resolution confocal microscope system capable of high-precision observations in the near-infrared [...]
AnalytiChem introduces Redipor® ready-to-use culture media brand globally
April 22, 2025
Redipor by AnalytiChem combining 150+ years of expertise in high quality prepared media, now manufactured in three production facilities worldwide. Eschborn, Germany -- AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has introduced Redipor® ready-to-use culture media as an AnalytiChem branded product line globally. Built on the legacy of three trusted brands – BioTrading, [...]
April 21, 2025
Singapore — BioChromatographix International (BCI), a pioneering biotech company developing breakthrough purification technologies, proudly announces its official public reveal. Headquartered in Singapore, BCI is redefining the standard for downstream processing with a new class of Next-Generation Monolithic Chromatography Media — purpose-built for the challenges of gene therapies, cell therapies, and advanced biologics manufacturing. Founded by [...]
Statement by the Board of Directors of Biotage in relation to the public offer from RWK BidCo
April 21, 2025
The Board of Directors of Biotage has concluded to recommend that the shareholders of Biotage accept the public offer from RWK BidCo, based on the assessment outlined below. Background This statement is made by the Board of Directors of Biotage AB (publ) (“Biotage” or the “Company”) (the “Board”) pursuant to section II.19 of the Nasdaq [...]
April 21, 2025
New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows CORALVILLE, Iowa - Ahead of the American Association for Cancer Research (AACR) 2025 Annual Meeting, global genomics solutions leader Integrated DNA Technologies (IDT) unveiled its xGen Hybridization and Wash v3 Kit, a newly designed target enrichment solution. The user-friendly workflow enables [...]
Process Insights Unveils the Lab NIR-O: A High-Precision NIR Spectroscopy Breakthrough
April 21, 2025
Process Insights Launches the GUIDED WAVE Lab NIR-O: Advanced NIR Spectroscopy for Unmatched Precision GUIDED WAVE Lab NIR-O Benchtop Analyzer from Process Insights HOUSTON, TX, UNITED STATES -- Process Insights, a global leader in industrial process monitoring solutions, is proud to announce the launch of its latest innovation: the GUIDED WAVE™ Lab NIR-O™ Benchtop Analyzer. Designed [...]
PAC Unveils New Name, Logo, and Brand Identity
April 21, 2025
PAC is proud to announce the launch of its new name, Precision Analyzer Company, along with an updated logo and brand identity. This change reflects the company’s continued commitment to its purpose of Moving the World Forward, Safely and Sustainably. The new logo symbolizes PAC’s ongoing commitment to innovation, delivering trusted insights, and empowering customers [...]
Rigaku and SPERA PHARMA initiate Strategic Partnership to Advanced Pharmaceutical Development
April 17, 2025
Tokyo, Japan; Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) and SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive [...]

